Sutro Biopharma

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next generation cancer and autoimmune therapeutics — antibody conjugates, bispecific antibodies and cytokine derivatives. Unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell.
Ticker:
STRO
Exchange:
Nasdaq
Company Type:
Not Provided
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2004
Main Therapeutic Focus:
Lead Product in Development:
Antibody-Drug Congugates and IADCs
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Sutro Biopharma